4//SEC Filing
PHARMATHENE, INC 4
Accession 0001144204-16-140974
$ALTCIK 0001326190operating
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:15 PM ET
Size
10.8 KB
Accession
0001144204-16-140974
Insider Transaction Report
Form 4
MACNEILL PHILIP
Controller and PAO
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-12-21$1.66/sh+17,657$29,311→ 126,346 total - Exercise/Conversion
Employee Stock Option (right to buy)
2016-12-21−17,657→ 35,312 totalExercise: $1.66Exp: 2025-12-03→ Common Stock (17,657 underlying) - Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-12-21$1.71/sh+5,000$8,550→ 108,689 total - Exercise/Conversion
Employee Stock Option (right to buy)
2016-12-21−5,000→ 5,000 totalExercise: $1.71Exp: 2024-12-08→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2014.
- [F2]These options were granted on December 3, 2015, and vest over a 3 year period with 25% vesting on the grant date and an additional 25% vesting on each of the first, second and third anniversaries of the grant date.
Documents
Issuer
PHARMATHENE, INC
CIK 0001326190
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001326190
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:15 PM ET
- Size
- 10.8 KB